Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

9
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

18
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

15
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
15
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

30
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

22
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
22

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tetralogy of Fallot: electrophysiology-guided surgical ablation during pulmonary valve replacement.

European heart journal·2026
Same author

Isolated extravascular implantable cardioverter-defibrillator infection without leadless pacemaker involvement: A unique dual-device case report.

HeartRhythm case reports·2026
Same author

Crossed wires: a shocking case of an subcutaneous-ICD lead jailed by sternal wires.

European heart journal. Case reports·2026
Same author

Polygenic and Monogenic Contributions to Tachycardia-Associated Cardiomyopathy.

Circulation·2026
Same author

Publisher Correction: Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial.

Nature medicine·2026
Same author

Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial.

Nature medicine·2026

Related Experiment Video

Updated: Jul 16, 2025

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

684

Rationale and Design of the Randomized Bayesian Multicenter COME-TAVI Trial in Patients With a New Onset Left Bundle

Lena Rivard1, Isabelle Nault2, Andrew D Krahn3

  • 1Department of Cardiology, Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.

CJC Open
|September 18, 2023
PubMed
Summary
This summary is machine-generated.

This study compares electrophysiology-guided management versus 30-day monitoring for patients with new left bundle branch block (LBBB) after transcatheter aortic valve implantation (TAVI). The goal is to determine the best strategy for preventing adverse cardiac events.

More Related Videos

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.5K
Three-Dimensional Echocardiographic Method for the Visualization and Assessment of Specific Parameters of the Pulmonary Veins
06:48

Three-Dimensional Echocardiographic Method for the Visualization and Assessment of Specific Parameters of the Pulmonary Veins

Published on: October 28, 2020

2.8K

Related Experiment Videos

Last Updated: Jul 16, 2025

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

684
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.5K
Three-Dimensional Echocardiographic Method for the Visualization and Assessment of Specific Parameters of the Pulmonary Veins
06:48

Three-Dimensional Echocardiographic Method for the Visualization and Assessment of Specific Parameters of the Pulmonary Veins

Published on: October 28, 2020

2.8K

Area of Science:

  • Cardiology
  • Electrophysiology
  • Interventional Cardiology

Background:

  • New-onset left bundle branch block (LBBB) following transcatheter aortic valve implantation (TAVI) increases the risk of delayed atrioventricular block.
  • Current management strategies for LBBB post-TAVI are not standardized and remain controversial.

Purpose of the Study:

  • To compare the clinical effectiveness of an electrophysiological study (EPS)-guided approach versus a 30-day electrocardiographic monitoring strategy for managing new-onset LBBB after TAVI.
  • To evaluate net clinical benefit by assessing a composite endpoint including cardiac death, syncope, and conduction disorders.

Main Methods:

  • A Bayesian multicenter randomized trial (COME-TAVI) comparing EPS-guided management with 30-day continuous electrocardiographic monitoring.
  • Patients with persistent LBBB on day 2 post-TAVI were randomized.
  • The EPS-guided arm involved pacemaker implantation if the His-ventricle (HV) interval was ≥ 65 ms.

Main Results:

  • The trial is ongoing, comparing a composite outcome of major adverse events between the two management strategies.
  • The study utilizes outcome-adaptive randomization and interim analyses.
  • Enrollment targets 452 patients to reach 77 primary outcome events over 12 months.

Conclusions:

  • The COME-TAVI trial aims to provide evidence-based guidance for managing new-onset LBBB post-TAVI.
  • Findings will inform clinical decision-making regarding pacemaker implantation versus monitoring.
  • This research addresses a critical unmet need in post-TAVI patient care.